Ceftolozane Sulfate

Records for this ingredient, by country (identity only).

ATC — · 3 markets · 3 records

Ceftolozane Sulfate 3 markets · 3 records Forms
Filters
MarketAU 1SG 1FR 1
Kind

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 1,147 mg per mL / per unit basis not statedinjection CombinationCeftolozane Sulfate 1,147 mg + Tazobactam Sodium 537 mgZERBAXA ceftolozane sulfate/tazobactam sodium 1000 mg/500 mg powder for injection vial unknown

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 1,000 mg per mL / per unit basis not statedinjection CombinationCeftolozane Sulfate 1,000 mg + Tazobactam Sodium 500 mgZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Combination products containing this ingredient

  • 1147 mg per mL / per unit basis not statedinjection CombinationCeftolozane Sulfate 1147 mg + Tazobactam Sodium 537 mgZERBAXA 1 g/0,5 g, poudre pour solution à diluer pour perfusion

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.